|
Date Submitted:
12/12/07
Hits: 13 Rating:  0/5 based on 0 votes
First Skin Patch Sanctioned for Alzheimer's
Description:
The Exelon skin patch (rivastigmine transdermal system) has been approved by the U.S. Food and Drug Administration to treat dementia associated with mild-to-moderate Alzheimer's disease, maker Novartis Pharmaceuticals said Monday.
Read the Complete Article Similar content: Skin Care and the Individual with Alzheimer's Disease, in Alzheimers RA Drugs Linked to Slight Skin Cancer Risk, in Arthritis Antioxidant Supplements May Raise Women's Skin Cancer Risk, in Prostate Cancer Health Tip: Postpone Alzheimer's?, in Alzheimers More Than 5 Million Americans Now Have Alzheimer's, in Alzheimers |
